Arcus Biosciences (RCUS)'s 30-day implied volatility (IV30) was 56.9% at the close on October 20, 2026, down from 93.5% the day before, against a 52-week range of 36.3% to 98.9%. Its 20-day historical volatility was 53.7%.
Data as of October 20, 2026.